tiprankstipranks
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
US Market
SNDX
Syndax Pharmaceuticals
RESEARCH TOOLSreports
Want to see SNDX full AI Analyst Report?

Syndax Pharmaceuticals (SNDX) Income Statement

916 Followers

Syndax Pharmaceuticals Income Statement

Last quarter (Q4 2025), Syndax Pharmaceuticals's total revenue was $68.48M, an increase of 791.68% from the same quarter last year. In Q4, Syndax Pharmaceuticals's net income was $-68.01M. See Syndax Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 172.35M$ 23.68M$ 0.00$ 0.00$ 139.71M
Gross Profit
$ 165.38M$ 22.85M$ 0.00$ 0.00$ 139.71M
Operating Expenses
$ 438.47M$ 362.53M$ 229.95M$ 151.76M$ 113.49M
Depreciation and Amortization
$ 6.00K$ 8.00K$ 12.00K$ 33.00K$ 43.00K
EBITDA
$ -251.64M$ -313.82M$ -209.14M$ -146.17M$ 26.87M
Operating Income
$ -273.08M$ -339.67M$ -229.95M$ -151.76M$ 26.22M
Other Income/Expenses
$ -12.34M$ 20.91M$ 20.59M$ 2.42M$ -1.29M
Pretax Income
$ -285.42M$ -318.76M$ -209.36M$ -149.34M$ 24.93M
Net Income
$ -285.42M$ -318.76M$ -209.36M$ -149.34M$ 24.93M
Per Share Metrics
Basic EPS
$ -3.30$ -3.73$ -2.98$ -2.46$ 0.48
Diluted EPS
$ -3.30$ -3.73$ -2.98$ -2.46$ 0.48
Weighted Average Shares Outstanding
 86.62M 85.62M 70.37M 60.76M 52.06M
Weighted Average Shares Outstanding (Diluted)
 86.62M 85.62M 70.37M 60.76M 52.06M
Currency in USD

Syndax Pharmaceuticals Earnings and Revenue History